Advising on Non-Core Disposals and Carve-Outs in Healthcare: How We Help

Advising on Healthcare Carve-Outs

As healthcare groups scale, particularly those backed by private equity or engaged in acquisition-led growth, there often comes a point where certain divisions, service lines or sites no longer align with the core strategic vision.

At Eclipse, we support healthcare operators by advising on carve-outs and divesting non-core assets, whether that’s a single site, a regional business unit, or an entire service line. These transactions demand a blend of strategic clarity, commercial pragmatism, and the willingness to get into the weeds.

Strategic Clarity + Practical Execution

We don’t just package a business for sale and send it into the market. We work closely with your team to:

• Clarify the strategic rationale for disposal

• Understand how the asset operates within the wider group

• Identify the likely buyer universe

• Ensure the value proposition is framed correctly

Financial Modelling: In Detail

Carve-outs often require bespoke financial modelling to isolate performance, and to show how the business will look post-transaction. This is where we’re different.

We build robust, defensible models that:

• Separate standalone revenue and cost bases

• Adjust for group dependencies (shared teams, IT, facilities)

• Allow buyers to model different integration or standalone scenarios

• Factor in transitional arrangements like TSAs and support costs

This often involves building or adapting bottom-up, department-level models, not just tweaking headline EBITDA. We don’t shy away from the detail.

Structuring for Success

Carve-outs will always require an element of structural complexity, including:

• Transitional Services Agreements (TSAs) covering IT, HR, finance or clinical oversight

• Phased transfers of staff, contracts, or licences

• Conditional consideration to reflect regulatory handovers or delayed separation

• Creative solutions for shared assets or joint use agreements

Our approach is tailored, practical, and grounded in what actually works — especially in regulated or multi-site settings like care, pharma services or specialist clinics.

Who We Work With

We advise:

• Private equity-backed healthcare groups refocusing after a roll-up phase

• Strategic operators reviewing underperforming or non-core divisions

• Healthcare corporates preparing for sale, seeking to streamline their structure

• Founders or boards exiting certain regions or service lines to reinvest elsewhere

Whether it’s part of a broader strategic review or a focused disposal, we provide hands-on, outcome-driven advice from initial feasibility through to deal completion.

Want to Discuss a Potential Carve-Out?

We’re always happy to have a confidential conversation, even at an early stage. Whether you’re considering options or ready to act, we can help you think clearly and execute with confidence.